Difference between revisions of "IL21R-AS1"
| Line 9: | Line 9: | ||
26857419 | 26857419 | ||
===Expression=== | ===Expression=== | ||
| − | qPCR analysis shows that IL21R-AS1 is 2.212-fold up-regulated in CAD (coronary artery disease) patients. | + | qPCR analysis shows that IL21R-AS1 is 2.212-fold up-regulated in CAD (coronary artery disease) patients. |
| − | [[File:Expression levels of CoroMarker, IL21R-AS1, BAT5, AC107016.1, and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients (n = 15) and control subjects (n = 15) (*P< 0.05 vs. control).jpg|right|thumb| | + | [[File:Expression levels of CoroMarker, IL21R-AS1, BAT5, AC107016.1, and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients (n = 15) and control subjects (n = 15) (*P< 0.05 vs. control).jpg|right|thumb|400px|'''Expression levels of CoroMarker, IL21R-AS1, BAT5, AC107016.1, and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients (n = 15) and control subjects (n = 15) (*P< 0.05 vs. control).''']] |
| − | |||
===Disease=== | ===Disease=== | ||
| − | coronary artery disease <ref name="ref1" /> | + | coronary artery disease. <ref name="ref1" /> |
==Labs working on this lncRNA== | ==Labs working on this lncRNA== | ||
| Line 21: | Line 20: | ||
==References== | ==References== | ||
<references> | <references> | ||
| − | <ref name="ref1"> | + | <ref name="ref1"> |
</ref>(1) | </ref>(1) | ||
</references> | </references> | ||
Revision as of 07:38, 15 October 2017
Contents
Annotated Information
Approved Symbol
IL21R-AS1 (IL21R antisense RNA 1)
Chromosome
16p12.1
RefSeq ID
NR_037158
pubmed IDs
26857419
Expression
qPCR analysis shows that IL21R-AS1 is 2.212-fold up-regulated in CAD (coronary artery disease) patients. [[File:Expression levels of CoroMarker, IL21R-AS1, BAT5, AC107016.1, and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients (n = 15) and control subjects (n = 15) (*P< 0.05 vs. control).jpg|right|thumb|400px|Expression levels of CoroMarker, IL21R-AS1, BAT5, AC107016.1, and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients (n = 15) and control subjects (n = 15) (*P< 0.05 vs. control).]]
Disease
coronary artery disease. [1]
Labs working on this lncRNA
- Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.
- Chongqing Institute of Cardiology, Chongqing, P.R. China.
